Literature DB >> 12458959

Optimisation by experimental design of a capillary electrophoretic method for the separation of several inhibitors of angiotensin-converting enzyme using alkylsulphonates.

S Hillaert1, Y Vander Heyden, W Van den Bossche.   

Abstract

A statistical experimental design was used to optimise a capillary electrophoretic separation method for eight inhibitors of the angiotensin-converting enzyme: enalapril, lisinopril, quinapril, fosinopril, perindopril, ramipril, benazepril, and cilazapril. Because a free solution capillary electrophoresis system did not achieve a complete separation of these eight compounds in one run, the usefulness of alkylsulphonates as ion-pairing agents was investigated. After preliminary investigations to determine the experimental domain and the most important factors, a three-level full-factorial design was applied to study the impact of the pH and the molarity of the ion-pairing agent on the separation. Improved separations were obtained suggesting a favourable effect of ion-pairing interactions between analytes and the additive; however, it remained impossible to separate them all in one run. A combination of two systems was still necessary for the selective identification of these structurally-related substances.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12458959     DOI: 10.1016/s0021-9673(02)01388-2

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  2 in total

1.  Thermo-, Radio- and Photostability of Perindopril Tert-butyloamine in The Solid State. Comparison to Other Angiotensin Converting Enzyme Inhibitors.

Authors:  Anna Wzgarda; Katarzyna Dettlaff; Martyna Rostalska; Ewa Pabian; Katarzyna Regulska; Beata Jadwiga Stanisz
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

2.  Switch on fluorescence probe for the selective determination of lisinopril in pharmaceutical formulations: application to content uniformity testing.

Authors:  Fatma F Mohammed; Khalid M Badr El-Din; Sayed M Derayea
Journal:  RSC Adv       Date:  2018-05-01       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.